 |
The Consult RoomAuthor: The Consult Room
The Consult Room is the podcast that explores the evolving world of modern pet care. Hosted by vet surgeon Dr Paul Manktelow, each episode dives into the key issues shaping the lives of pets and the people who love them. Whether you're looking for deeper insight into modern veterinary healthcare, curious about the pet care industry, or simply passionate about animal welfare, The Consult Room brings clarity, compassion, and real-world expertise to the conversation. Visit www.theconsultroom.co.uk or get in touch at hello@theconsultroom.co.uk. Language: en Genres: Kids & Family, Pets & Animals Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
CBD for Pets: Miracle Cure or Clever Marketing?
Tuesday, 7 July, 2026
In this episode of The Consult Room, I explore a topic popping up all over our social feeds: CBD and CBG products for pets.Marketed for everything from arthritis to anxiety, these products are either seen as a healthcare revolution or expensive hype. But what does science actually say? In this episode, I step back from the noise to look at how cannabinoids interact with the animal body, the confusing UK legal landscape, and where the research is genuinely promising. Most importantly, I address the gap between consumer demand and scientific reality - particularly when it comes to pet anxiety.While there is exciting potential on the horizon, the unregulated market requires pet owners and vets to approach these products with a healthy dose of caution.In This EpisodeWhat CBD and CBG actually are, and how they differ from THCHow cannabinoids interact with the endocannabinoid systemWhy the strongest evidence supports treating arthritis and chronic pain, not anxietyThe nuanced research surrounding CBD use in canine epilepsyThe distinct lack of veterinary data supporting the rise of CBGPotential side effects and the critical need for veterinary oversightThe widespread issues regarding product quality and label accuracyThe complex UK legal position and the stance of the VMDKey TakeawaysAnecdotes are not evidence: Personal success stories do not equal scientific proof.Demand outpaces the science: Marketing for pet anxiety is massive, but the clinical data remains highly inconsistent.Label accuracy is a major hurdle: Many products do not contain what they claim, and some even contain psychoactive THC."Natural" does not mean safe: Potential side effects and drug interactions mean professional veterinary guidance is essential.Good medicine demands balance: We shouldn't dismiss cannabinoids outright, but curiosity must be paired with caution.🎙️ If you enjoy thoughtful discussions like this, follow The Consult Room and share it with someone who would find this topic interesting.
